
Tacalyx GmbH raises €7m in seed funding
The financing was co-led by Boehringer Ingelheim Venture Fund and Kurma Partners. Idinvest Partners, High-Tech Gründerfonds (HTGF), coparion,...

Spanish sector attracting more and more investment
According to Spain's biotech association, the investor day attracted 60 investors from nine countries and provided more than 500 partnering...

Second clinical failure of Transgene in 2019
French Transgene SA (Strasbourg, France) has announced another study failure, following the Phase III flop of its oncolytic virus programme this...

Lundback swallows migraine drug maker Alder
Alder's first-in-class monoclonal antibody for migraine prevention, eptinezumab, targets the calcitonin gene-related peptide and faces FDA...

Ermium Therapeutics bags €6.3m in Series A round
Domain Therapeutics, Kurma Partners, Idinvest, and the SATT Erganeo contributed to the financing. Ermium Therapeutics has licenced exclusively...

Rottapharm Biotech: POC in osteoarthritis pain
Results of the proof-of-concept trial suggest the selective imidazoline-2 (I2) receptor agonist CR4056 could be an alternative to the...

Tecentriq-Avastin combo hits endpoint in liver cancer
Data from 501 treatment-native HCC patients enrolled in the open label IMbrave150 Phase III study demonstrated a incremental improvement...